These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 8961990)
1. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working Party. Lancet; 1996 Dec; 348(9042):1610-4. PubMed ID: 8961990 [TBL] [Abstract][Full Text] [Related]
2. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet; 1996 Dec; 348(9042):1605-10. PubMed ID: 8961989 [TBL] [Abstract][Full Text] [Related]
3. Short versus conventional preoperative radiotherapy of rectal cancer: indications. Klenova A; Georgiev R; Kurtev P; Kurteva G J BUON; 2007; 12(2):227-32. PubMed ID: 17600877 [TBL] [Abstract][Full Text] [Related]
4. Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Swedish Rectal Cancer Trial. Eur J Surg; 1996 May; 162(5):397-402. PubMed ID: 8781922 [TBL] [Abstract][Full Text] [Related]
5. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer. Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464 [TBL] [Abstract][Full Text] [Related]
6. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Sebag-Montefiore D; Stephens RJ; Steele R; Monson J; Grieve R; Khanna S; Quirke P; Couture J; de Metz C; Myint AS; Bessell E; Griffiths G; Thompson LC; Parmar M Lancet; 2009 Mar; 373(9666):811-20. PubMed ID: 19269519 [TBL] [Abstract][Full Text] [Related]
7. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Erlandsson J; Holm T; Pettersson D; Berglund Å; Cedermark B; Radu C; Johansson H; Machado M; Hjern F; Hallböök O; Syk I; Glimelius B; Martling A Lancet Oncol; 2017 Mar; 18(3):336-346. PubMed ID: 28190762 [TBL] [Abstract][Full Text] [Related]
8. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer. Zhan T; Gu J; Li M; Du C Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609 [TBL] [Abstract][Full Text] [Related]
9. Local excision and postoperative radiotherapy for distal rectal cancer. Benson R; Wong CS; Cummings BJ; Brierley J; Catton P; Ringash J; Abdolell M Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1309-16. PubMed ID: 11483343 [TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661 [TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T; Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067 [TBL] [Abstract][Full Text] [Related]
12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome. Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638 [TBL] [Abstract][Full Text] [Related]
14. Preoperative radiotherapy for operable rectal cancer--is a lower dose to a reduced volume acceptable? Saunders MP; Alderson H; Chittalia A; Hughes S; James RD; Armstrong G; Swindell R; Scott NA Clin Oncol (R Coll Radiol); 2006 Oct; 18(8):594-9. PubMed ID: 17051949 [TBL] [Abstract][Full Text] [Related]
15. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ; Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156 [TBL] [Abstract][Full Text] [Related]